A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.
Takahashi S, Kiyota N, Yamazaki T, Chayahara N, Nakano K, Inagaki L, Toda K, Enokida T, Minami H, Imamura Y, Fukuda N, Sasaki T, Suzuki T, Ikezawa H, Dutcus CE, Tahara M.
Takahashi S, et al. Among authors: fukuda n.
Future Oncol. 2019 Mar;15(7):717-726. doi: 10.2217/fon-2018-0557. Epub 2019 Jan 14.
Future Oncol. 2019.
PMID: 30638399
Free article.
Clinical Trial.